3 recruiting, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Active not recruiting 1 |
Follow Urachal adenocarcinoma: new trials by email Literature Review of Urachal adenocarcinoma trials Research Report on Urachal adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Agnostic Therapy in Rare Solid Tumors Nivolumab - Urachal Cancer, Parathyroid Carcinoma | Phase 2 | Active not recruiting | Instituto do Cancer do Estado de São Paulo | 28 | 2024-07-16 | 2026-10-13 |
| Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology Biospecimen Collection, Computed Tomography, Enfortumab Vedotin - Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma | Phase 2 | Recruiting | Emory University | 25 | 2023-09-26 | 2026-07-29 |
| A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies Urothelial Cancer, Bladder Cancer | Recruiting | National Cancer Institute (NCI) | 1100 | 2022-10-24 | 2026-10-16 | |
| Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors Biospecimen Collection, Bone Scan, Cabozantinib S-malate - Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 314 | 2019-05-13 | 2026-10-28 |
Penile Neoplasms (3) · Urinary Bladder Neoplasms (3) · Carcinoma, Renal Cell (2) · Urethral Neoplasms (2) · Urogenital Neoplasms (2) · Adrenal Gland Neoplasms (1) · Anus Neoplasms (1) · Biliary Tract Neoplasms (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Transitional Cell (1) · Carcinosarcoma (1) · Cholangiocarcinoma (1) · Endodermal Sinus Tumor (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Urologic Neoplasms (4) · Adenocarcinoma (3) · Carcinoma (3) · Genital Diseases (3) · Genital Diseases, Male (3) · Genital Neoplasms, Male (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3)
Magnetic Resonance Spectroscopy (2) · Nivolumab (2) · Specimen Handling (2) · CTLA-4 Antigen (1) · Ipilimumab (1) · cabozantinib (1) · enfortumab vedotin (1) · pembrolizumab (1)
National Cancer Institute (NCI) (2) · Emory University (1) · Instituto do Cancer do Estado de São Paulo (1)
United States (3) · Brazil (1) · Puerto Rico (1)
Andrea B Apolo (1) · Andrea B Apolo, M.D. (1) · Camila MV Moniz, Doctor (1) · Jacqueline Brown, MD (1)
P30CA138292 (1), U10CA180821 (1)